Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Rrm1 in peripheral blood is predictive of shorter survival in Chinese patients with advanced NSCLC treated by Gemcitabine and platinum

  • At: 2011 FIP Congress in Hyderabad (India)
  • Type: Poster
  • By: WANG, Lin-Run (The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China)
  • Co-author(s): Zhang, Guo-bing (The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China)
    Chen, Jian (The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China)
    Li, Jun (The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China)
    Li, Ming-Wei (The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China)
    Xu, Nong (The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China)
    Wang, Yang (The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China)
    Shen Tu, Jian-Zhong (The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China)
  • Abstract:

    Objective: To evaluate the predictive value of gene expression of ribonucleotide reductase M1 (RRM1) and breast cancer susceptibility gene 1 (BRCA1) in peripheral blood from Chinese patients with non-small-cell lung cancer (NSCLC) treated with gemcitabine plus platinum. Methods: Forty Chinese patients with advanced NSCLC were recruited and..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses